Literature DB >> 25931333

Butyrylcholinesterase-knockout reduces brain deposition of fibrillar β-amyloid in an Alzheimer mouse model.

G Andrew Reid1, Sultan Darvesh2.   

Abstract

In Alzheimer's disease (AD), numerous β-amyloid (Aβ) plaques are associated with butyrylcholinesterase (BChE) activity, the significance of which is unclear. A mouse model, containing five human familial AD genes (5XFAD), also develops Aβ plaques with BChE activity. Knock-out of BChE in this model showed diminished fibrillar Aβ plaque deposition, more so in males than females. This suggests that lack of BChE reduces deposition of fibrillar Aβ in AD and this effect may be influenced by sex.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  5XFAD mouse; Alzheimer’s disease; butyrylcholinesterase; butyrylcholinesterase-knockout; cholinergic system; β-amyloid

Mesh:

Substances:

Year:  2015        PMID: 25931333     DOI: 10.1016/j.neuroscience.2015.04.039

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  21 in total

Review 1.  Cholinesterases and the fine line between poison and remedy.

Authors:  Carey N Pope; Stephen Brimijoin
Journal:  Biochem Pharmacol       Date:  2018-01-31       Impact factor: 5.858

2.  Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.

Authors:  Mehrdad Sadafi Kohnehshahri; Gholamabbas Chehardoli; Masoomeh Bahiraei; Tahmineh Akbarzadeh; Akram Ranjbar; Arezoo Rastegari; Zahra Najafi
Journal:  Mol Divers       Date:  2021-09-07       Impact factor: 2.943

3.  Biochemical Analysis and Association of Butyrylcholinesterase SNPs rs3495 and rs1803274 with Substance Abuse Disorder.

Authors:  Sadaf Munir; Rabia Habib; Sliha Awan; Nazia Bibi; Arooj Tanveer; Sajida Batool; Syed M Nurulain
Journal:  J Mol Neurosci       Date:  2019-02-01       Impact factor: 3.444

4.  Enhancement of Fear Extinction Memory and Resistance to Age-Related Cognitive Decline in Butyrylcholinesterase Knockout Mice and (R)-Bambuterol Treated Mice.

Authors:  Weiwei Liu; Yan Cao; Yue Lin; Keai Sinn Tan; Haishan Zhao; Haihua Guo; Wen Tan
Journal:  Biology (Basel)       Date:  2021-05-05

Review 5.  The diabetic brain and cognition.

Authors:  Peter Riederer; Amos D Korczyn; Sameh S Ali; Ovidiu Bajenaru; Mun Seong Choi; Michael Chopp; Vesna Dermanovic-Dobrota; Edna Grünblatt; Kurt A Jellinger; Mohammad Amjad Kamal; Warda Kamal; Jerzy Leszek; Tanja Maria Sheldrick-Michel; Gohar Mushtaq; Bernard Meglic; Rachel Natovich; Zvezdan Pirtosek; Martin Rakusa; Melita Salkovic-Petrisic; Reinhold Schmidt; Angelika Schmitt; G Ramachandra Sridhar; László Vécsei; Zyta Beata Wojszel; Hakan Yaman; Zheng G Zhang; Tali Cukierman-Yaffe
Journal:  J Neural Transm (Vienna)       Date:  2017-08-01       Impact factor: 3.575

6.  Parental Lead Exposure Promotes Neurobehavioral Disorders and Hepatic Dysfunction in Mouse Offspring.

Authors:  Hasan Ul Banna; Adiba Anjum; Sheta Biswas; Victor Mondal; Abu Eabrahim Siddique; Apurba Kumar Roy; Farjana Nikkon; Azizul Haque; Seiichiro Himeno; Kazi Abdus Salam; Khaled Hossain; Zahangir Alam Saud
Journal:  Biol Trace Elem Res       Date:  2021-04-08       Impact factor: 3.738

7.  Dysregulated Homeostasis of Acetylcholine Levels in Immune Cells of RR-Multiple Sclerosis Patients.

Authors:  Maria Di Bari; Marcella Reale; Marta Di Nicola; Viviana Orlando; Sabrina Galizia; Italo Porfilio; Erica Costantini; Chiara D'Angelo; Serena Ruggieri; Stefano Biagioni; Claudio Gasperini; Ada Maria Tata
Journal:  Int J Mol Sci       Date:  2016-11-30       Impact factor: 5.923

8.  Synthesis and Initial Characterization of a Reversible, Selective 18F-Labeled Radiotracer for Human Butyrylcholinesterase.

Authors:  Christian Gentzsch; Xinyu Chen; Philipp Spatz; Urban Košak; Damijan Knez; Naoko Nose; Stanislav Gobec; Takahiro Higuchi; Michael Decker
Journal:  Mol Imaging Biol       Date:  2021-03-03       Impact factor: 3.488

9.  Antiaggregation Potential of Padina gymnospora against the Toxic Alzheimer's Beta-Amyloid Peptide 25-35 and Cholinesterase Inhibitory Property of Its Bioactive Compounds.

Authors:  Balakrishnan Shanmuganathan; Dicson Sheeja Malar; Sethuraman Sathya; Kasi Pandima Devi
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

10.  Amyloid-β peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAβACs.

Authors:  Rajnish Kumar; Agneta Nordberg; Taher Darreh-Shori
Journal:  Brain       Date:  2015-11-02       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.